We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.8B
AUM Growth
+$1.27B
(+3.7%)
Cap. Flow
-$817M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,236
Closed
310
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$563M |
| 2 |
McDonald's
MCD
|
+$357M |
| 3 |
Tesla
TSLA
|
+$268M |
| 4 |
Advanced Micro Devices
AMD
|
+$253M |
| 5 |
PayPal
PYPL
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$485M |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Merck
MRK
|
+$217M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Healthcare | 17.85% |
| 3 | Industrials | 11.58% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRDG
2251
DELISTED
Bridge Investment Group
BRDG
| $140K | ﹤0.01% |
11,600
-18,900
| -62% | -$272K |
|
|
FLNT
2252
Fluent
FLNT
$103M
| $137K | ﹤0.01% |
20,983
-11,400
| -35% | -$83.7K |
|
|
STSA
2253
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $137K | ﹤0.01% |
152,300
+117,500
| +338% | +$340K |
|
2254
Interface
TILE
$2B
| $136K | ﹤0.01% |
13,800
+3,100
| +29% | +$32.6K |
|
2255
Ginkgo Bioworks
DNA
$503M
| $134K | ﹤0.01% |
+1,979
| New | +$182K |
|
2256
China Yuchai International
CYD
$1.74B
| $134K | ﹤0.01% |
18,890
-3,300
| -15% | -$24.1K |
|
2257
Sabra Healthcare REIT
SBRA
$5.61B
| $133K | ﹤0.01% |
10,700
-42,600
| -80% | -$543K |
|
|
CYPH
2258
Cypherpunk Technologies Inc
CYPH
$65.4M
| $133K | ﹤0.01% |
29,550
-11,860
| -29% | -$79.3K |
|
2259
Amplitude
AMPL
$1.16B
| $133K | ﹤0.01% |
11,000
-100
| -0.9% | -$1.42K |
|
2260
Pennant Group
PNTG
$1.46B
| $130K | ﹤0.01% |
+11,800
| New | +$128K |
|
2261
Orion Group Holdings
ORN
$485M
| $129K | ﹤0.01% |
54,300
-10,200
| -16% | -$24.6K |
|
2262
UWM Holdings
UWMC
$631M
| $129K | ﹤0.01% |
38,900
-9,800
| -20% | -$36.7K |
|
|
CTEV
2263
Claritev Corp
CTEV
$386M
| $128K | ﹤0.01% |
2,793
+215
| +8% | +$17.2K |
|
|
MACK
2264
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $128K | ﹤0.01% |
11,181
-7,500
| -40% | -$61.8K |
|
2265
Neurogene
NGNE
$663M
| $127K | ﹤0.01% |
12,515
-7,185
| -36% | -$74.2K |
|
|
AAN
2266
DELISTED
The Aaron's Company Inc
AAN
| $127K | ﹤0.01% |
10,600
-400
| -4% | -$4.28K |
|
2267
Protara Therapeutics
TARA
$221M
| $127K | ﹤0.01% |
47,218
-5,200
| -10% | -$16.4K |
|
|
BGFV
2268
DELISTED
Big 5 Sporting Goods
BGFV
| $125K | ﹤0.01% |
14,200
-54,100
| -79% | -$622K |
|
2269
Akebia Therapeutics
AKBA
$341M
| $125K | ﹤0.01% |
217,149
+1,200
| +0.6% | +$376 |
|
|
BRMK
2270
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $125K | ﹤0.01% |
35,000
-4,400
| -11% | -$20.5K |
|
|
ARAV
2271
DELISTED
Aravive, Inc. Common Stock
ARAV
| $124K | ﹤0.01% |
94,215
+51,100
| +119% | +$65.2K |
|
2272
ADT
ADT
$5.38B
| $124K | ﹤0.01% |
+13,629
| New | +$121K |
|
2273
Spyre Therapeutics
SYRE
$8.68B
| $123K | ﹤0.01% |
10,912
-5,484
| -33% | -$98.6K |
|
2274
Macerich
MAC
$7.52B
| $122K | ﹤0.01% |
10,800
-156,000
| -94% | -$1.76M |
|
2275
Natural Gas Services Group
NGS
$460M
| $121K | ﹤0.01% |
10,577
-200
| -2% | -$2.18K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Two Sigma Advisers held 2,806 positions worth $35.8B, up 3.7% from $34.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q4 2022 filing shows 288 new, 941 increased, 1,236 reduced and 310 closed positions. Its largest new stake was Advanced Micro Devices: 3,833,640 shares worth $248M. The largest sale was JPMorgan Chase, an estimated $485M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q4 2022 buy was Advanced Micro Devices: 3,833,640 shares worth $248M.
- Two Sigma Advisers added most to Amazon in Q4 2022, an estimated $563M increase.
- Two Sigma Advisers's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $485M.
- Two Sigma Advisers fully exited NVIDIA in Q4 2022, selling an estimated $140M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $35.8B portfolio in Q4 2022.
- Two Sigma Advisers opened 288 new positions and closed 310 in Q4 2022.
- Two Sigma Advisers's portfolio value rose 3.7% quarter-over-quarter to $35.8B.
Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.